This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Santa Clara University, University of California, University of South Florida. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2024
Title: Ghada Alzamzmi: Innovator in Neural Networks for Drug Side Effect Prediction
Introduction
Ghada Alzamzmi is a notable inventor based in Rockville, MD (US). She has made significant contributions to the field of neural networks, particularly in predicting drug side effects. Her innovative approach combines advanced technology with pharmacological insights to enhance patient safety.
Latest Patents
Ghada holds a patent for her invention titled "Multimodal cell complex neural networks for prediction of multiple drug side effects severity and frequency." This method involves training a multi-modal cell complex neural network (MCXN) on a dataset that includes drugs and proteins. The MCXN is designed to predict the probabilities of potential side effects when multiple drugs are administered concurrently. It also forecasts the frequency and severity of these side effects, providing valuable information for healthcare professionals.
Career Highlights
Throughout her career, Ghada has worked with prestigious institutions such as Santa Clara University and the University of California. Her experience in these academic environments has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Ghada has collaborated with notable colleagues, including Mustafa Hajij and Nina Miolane. These partnerships have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Ghada Alzamzmi's innovative work in neural networks represents a significant advancement in predicting drug side effects. Her contributions are poised to improve patient outcomes and enhance the safety of drug administration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile